Informed consent in clinical trials in critical care: experience from the PAC-Man Study
- First Online:
- 221 Downloads
To identify the proportion of critically ill patients able to consent to participation in a randomised controlled trial (RCT) and to assess to what extent patient consent and relative assent processes could be conducted according to ethics committee permissions.
Descriptive study nested in an RCT.
Fifty-six UK intensive care units participating in the PAC-Man trial.
Patients and participants
First 500 patients consecutively enrolled into PAC-Man.
Measurement and results
The outcome measures were patient consent and/or relative assent. Of the 498 patients included, 13 (2.6%) provided consent before randomisation. Of the remaining 485 patients, relative assent was obtained for 394 patients (81.2%), and refused post-randomisation for 3 patients (0.6%). No relatives were available for 15 patients (3.1%), and it was unclear from documentation whether relative assent had been obtained for 73 patients (15.1%). Of the 482 patients who did not provide consent prior to randomisation, 188 (39%) survived. Of these, 175 (93.1%) gave retrospective informed consent, six (3.2%) refused, and seven (3.7%) did not regain mental competency.
A very small proportion of patients were able to give consent before randomisation. Due to the high in-hospital mortality (60.6%), only around one third of the remaining patients could provide consent retrospectively. This study demonstrates difficulties experienced in obtaining consent from critically ill patients to participate in medical research and raises important issues about the ethical basis of the consent process in critical care.
KeywordsIntensive care Clinical trial Ethics Consent
- 2.Beauchamp TL, Childress JF (1994) Principles of biomedical ethics. 4th edn. Oxford University Press, New YorkGoogle Scholar
- 5.Harvey S, Harrison DA, Singer M, Ashcroft J, Jones CM, Elbourne D, Brampton W, Williams D, Young D, Rowan K, PAC-Man study collaboration (2005) Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 366:472–477PubMedCrossRefGoogle Scholar
- 7.Lewis RJ, Berry DA, Cryer H, Fost N, Krome R, Washington GR, Houghton J, Blue JW, Bechhofer R, Cook T, Fisher M (2001) Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: the Diaspirin Cross-Linked Hemoglobin Traumatic Hemorrhagic Shock Efficacy Trial. Ann Emerg Med 38:397–404PubMedCrossRefGoogle Scholar
- 10.McClure KB, DeIorio NM, Gunnels MD, Ochsner MJ, Biros MH, Schmidt TA (2003) Attitudes of emergency department patients and visitors regarding emergency exception from informed consent in resuscitation research, community consultation, and public notification. Acad Emerg Med 10:352–359PubMedCrossRefGoogle Scholar
- 11.Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, Cottingham R, Svoboda P, Brayley N, Mazairac G, Laloe V, Munoz-Sanchez A, Arango M, Hartzenberg B, Khamis H, Yutthakasemsunt S, Komolafe E, Olldashi F, Yadav Y, Murillo-Cabezas F, Shakur H, Edwards P, CRASH trial collaborators (2004) Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 364:1321–1328PubMedCrossRefGoogle Scholar
- 12.CESAR Trial, http://www.cesar-trial.org (accessed 25 October 2005)Google Scholar
- 13.TracMan Trial,http://www.tracman.org.uk (accessed 25 October 2005)Google Scholar
- 14.CRASH Trial Management Group (2004) Research in emergency situations: with or without relatives' consent. Emerg Med J 21:703Google Scholar
- 17.Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001, http://eudract.emea.eu.int/docs/Dir2001-20_en.pdf (accessed 25 October 2005)Google Scholar
- 18.Medicines for Human Use (Clinical Trials Regulations) 2004. Informed consent in clinical trials (7th February 2005), http://www.corec.org.uk/applicants/help/docs/Informed_Consent_in_CTIMPsv1.1.doc (accessed 25 October 2005)Google Scholar